Advantage Investment Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$18K Sell
84
-100
-54% -$20.9K 0.01% 539
2019
Q2
$36K Buy
184
+100
+119% +$18.4K 0.03% 409
2019
Q1
$14K Sell
84
-56
-40% -$9.9K 0.01% 590
2018
Q4
$26K Sell
140
-154
-52% -$28.4K 0.02% 464
2018
Q3
$50K Buy
294
+185
+170% +$31.1K 0.03% 386
2018
Q2
$18K Hold
109
0.01% 558
2018
Q1
$18K Sell
109
-320
-75% -$50.9K 0.01% 570
2017
Q4
$63K Buy
429
+312
+267% +$44.4K 0.02% 362
2017
Q3
$16K Sell
117
-34
-23% -$4.29K 0.01% 587
2017
Q2
$19K Buy
151
+25
+20% +$2.99K 0.01% 566
2017
Q1
$15K Buy
+126
New +$15.2K 0.01% 601

Other funds holding CME

Advantage Investment Management's CME Position: Q3 2019 in Review

Advantage Investment Management reduced its CME Group (CME) stake by 54% in Q3 2019, selling an estimated $20.9K and leaving 84 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #539.

Advantage Investment Management first reported a position in CME in Q1 2017 and has held it in 11 quarters since. The position peaked at $63K in Q4 2017. 991 funds tracked by Wall St. Rank hold CME as of Q3 2019.

  • Advantage Investment Management held 84 shares of CME Group worth $18K as of Q3 2019.
  • Advantage Investment Management sold 100 CME Group shares in Q3 2019, an estimated $20.9K.
  • CME Group made up 0.01% of Advantage Investment Management's portfolio in Q3 2019, its #539 holding.
  • Advantage Investment Management first reported a position in CME Group in Q1 2017 and has held it in 11 quarters since.
  • Advantage Investment Management's CME Group position peaked at $63K in Q4 2017.
  • 991 funds tracked by Wall St. Rank held CME Group as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.